WeVote
Log In

Bill

Bill

HB 69

Relating to the provision of an abortion-inducing drug.

89th Legislature, 1st Called Session (2025) Introduced by Ellen Troxclair

Texas bill addressing regulation or restrictions on medication abortion drugs, likely affecting healthcare provider authority and patient access to mifepristone-based abortion care.

Filed
#abortion(i0005) #healthcareproviders(i0387) #medicine&prescriptiondrugs(s7338) #occupationalregulation--healthoccupations(i0540) #physicians(s1282) #pregnancy&childbirth(s0294)
0
WeVote Research Nonpartisan
Bill Summary · HB 69

Legislative bill overview

HB 69 addresses the provision of abortion-inducing drugs, likely mifepristone and misoprostol used in medication abortion. The bill was recently filed in the Texas House and is sponsored by Ellen Troxclair. Without access to the full bill text, the specific provisions—whether restrictive, permissive, or regulatory—cannot be detailed.

Why this is important

Medication abortion accounts for a growing share of U.S. abortions and is a significant point of contention in abortion policy. Texas currently has strict abortion restrictions, making this bill potentially impactful for reproductive healthcare access or enforcement in the state.

Potential points of contention

  • Federal vs. state authority: Medication abortion involves FDA-approved drugs; state restrictions may conflict with federal regulatory authority
  • Healthcare provider scope: Disputes over who can prescribe/dispense these drugs (physicians, nurse practitioners, pharmacists) and under what conditions
  • Access and enforcement mechanisms: Questions about criminal penalties, civil liability, and how restrictions would be enforced against providers or patients

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.